REPOCEUTICALS A/S: Financial statements 2017
CVR: 36494433
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -77,881 compared with DKK -211,162 the year before. Equity in the 2017 report amounted to DKK 26,922. The solvency ratio was 1.1%.
- Profit/Loss
- DKK -77,881
- Equity
- DKK 26,922
- Total Assets
- DKK 2,515,347
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -78K | 27K | - |
| 2016 | - | - | -211K | 105K | - |
| 2015 | - | - | -34K | 316K | - |
Official annual report
Keep an eye on REPOCEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
REPOCEUTICALS A/S has published its annual report for 2016. The net result was DKK -211,162.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.